InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Immatics N.V.

IMTX Clue Score43
Germany Fiscal year ends December CIK 0001809196
$7.43 +0.81% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $7.43 −44.47% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 2 Jul 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Operating incomeNet income
Fiscal year 2018Operating income−34.4Net income−31.4Fiscal year 2019Operating income−33.0Net income−31.6Fiscal year 2020Operating income−69.7Net income−211.3EPS, diluted−4.40Fiscal year 2021Operating income−86.3Net income−93.3EPS, diluted−1.48Fiscal year 2022Operating income30.0Net income27.7EPS, diluted0.40Fiscal year 2023Operating income−101.7Net income−94.6 −441.7%EPS, diluted−1.18 −395.0%Fiscal year 2024Operating income−38.6Net income15.2EPS, diluted0.14Fiscal year 2025Operating income−182.0Net income−196.4 −1,390.9%EPS, diluted−1.61 −1,250.0%
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating income −34.4 −33.0 −69.7 −86.3 30.0 −101.7 −38.6 −182.0
Net income −31.4 −31.6 −211.3 −93.3 27.7 −94.6 15.2 −196.4
Growth −441.7% −1,390.9%
EPS, diluted n/a n/a −4.40 −1.48 0.40 −1.18 0.14 −1.61
Growth −395.0% −1,250.0%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2018Operating cash flow20.7Capital expenditure−0.4Free cash flow20.3Fiscal year 2019Operating cash flow71.0Capital expenditure−2.1Free cash flow68.8 +239.8%Fiscal year 2020Operating cash flow−80.7Capital expenditure−7.4Free cash flow−88.1 −228.0%Fiscal year 2021Operating cash flow−84.7Capital expenditure−5.1Free cash flow−89.9Fiscal year 2022Operating cash flow100.1Capital expenditure−5.7Free cash flow94.4Fiscal year 2023Operating cash flow18.2Capital expenditure−30.8Free cash flow−12.6 −113.3%Fiscal year 2024Operating cash flow−158.0Capital expenditure−16.3Free cash flow−174.3Fiscal year 2025Operating cash flow−176.6Capital expenditure−6.6Free cash flow−183.2
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 20.7 71.0 −80.7 −84.7 100.1 18.2 −158.0 −176.6
Capital expenditure −0.4 −2.1 −7.4 −5.1 −5.7 −30.8 −16.3 −6.6
Free cash flow 20.3 68.8 −88.1 −89.9 94.4 −12.6 −174.3 −183.2
Growth +239.8% −228.0% −113.3%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2018Cash39.4Shareholders’ equity−9.2Fiscal year 2019Cash103.4Shareholders’ equity−41.9Fiscal year 2020Cash207.5Shareholders’ equity87.4Fiscal year 2021Cash133.0Shareholders’ equity24.1Fiscal year 2022Cash148.5Shareholders’ equity203.4Fiscal year 2023Cash218.5Shareholders’ equity217.6Fiscal year 2024Cash236.7Shareholders’ equity574.8Fiscal year 2025Cash345.9Shareholders’ equity484.1
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 39.4 103.4 207.5 133.0 148.5 218.5 236.7 345.9
Shareholders’ equity −9.2 −41.9 87.4 24.1 203.4 217.6 574.8 484.1

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
34.0 40.1 67.1 87.6 106.8 118.7 148.1 183.8
7.7 11.8 34.2 33.8 36.1 38.2 46.4 51.2
−34.4 −33.0 −69.7 −86.3 30.0 −101.7 −38.6 −182.0
Growth −439.6%
−32.4 −32.5 −211.8 −93.3 42.0 −97.0 21.3 −198.4
0.0 0.0 0.0 0.0 14.3 −2.3 6.1 −2.0
−31.4 −31.6 −211.3 −93.3 27.7 −94.6 15.2 −196.4
Growth −441.7% −1,390.9%
Per share
n/a n/a −4.40 −1.48 0.41 −1.18 0.14 −1.61
n/a n/a −4.40 −1.48 0.40 −1.18 0.14 −1.61
Growth −395.0% −1,250.0%
33.1 33.1 48.0 62.9 67.2 80.5 105.7 122.3
n/a n/a 48.0 62.9 68.8 80.5 106.8 122.3
Growth +31.1% +9.4% +17.0% +32.6% +14.6%

Five years in brief

Worked out from the figures above, not from a press release
  • The diluted share count rose 154.9% in five years, which is dilution.
  • A net loss in 6 of 8 years on file.